Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Article

    Docetaxel-induced hand foot syndrome: “No dose is a safe dose”

    Ankit Jain1★, Biswajit Dubashi1★ Corresponding author

    1. 1Department of Medical Oncology, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry 6, India Case Report.

    CORRESPONDENCE

    Ankit Jain

    Department of Medical Oncology, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry 6, India Case Report.

    Volume 3, Issue 2 · pp. 200–201 · PUBLISHED 2012 · DOI: 10.4103/0976-500X.95534

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Docetaxel is an important chemotherapeutic agent used in the management of many solid tumors. The most important side effect of this drug is myelosupression. We report a case of carcinoma breast that developed severe hand-foot syndrome at 75 mg/m2 doses of docetaxel. The exact mechanism of this side effect in not known. All the physicians using this drug must be aware of this side effect.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Jain, A., & Dubashi, B. (2012). Docetaxel-induced hand foot syndrome: “No dose is a safe dose”. Journal of Pharmacology and Pharmacotherapeutics, 3(2), 200–201. https://doi.org/10.4103/0976-500X.95534